R. Corcoran
Molecular Biology · 2010–2021
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 84 citations into it
Whom R. Corcoran trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from R. Corcoran's perspective
Ordered by how strongly the researchers R. Corcoran trusts endorse each paper. Same corpus, a different order for every researcher.
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)
- Mutations of the BRAF gene in human cancer (Nature)
- Ras, PI(3)K and mTOR signalling controls tumour cell growth (Nature)
- The phosphoinositide 3-kinase pathway. (Science)
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism (Nature reviews genetics)
- Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. (Journal of Clinical Oncology)
- PI3K pathway alterations in cancer: variations on a theme (Oncogene)
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
- Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. (Annual Review of Cell and Developmental Biology)
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth (Nature)
Their papers
- EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib (2012) — 944 citations
- Spatially organized multicellular immune hubs in human colorectal cancer (2021) — 691 citations
- The PI3K pathway as drug target in human cancer. (2010) — 1,284 citations
- Application of Cell-free DNA Analysis to Cancer Treatment. (2018) — 794 citations
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation (2017) — 857 citations
- Monitoring clonal evolution and resistance to EGFR blockade in the blood of metastatic colorectal cancer patients (2015) — 997 citations